Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global ...

Doximity's fiscal 2025 Q2 earnings beat analyst and management expectations despite ongoing macroeconomic uncertainties in ...

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts ...

Morgan Stanley has upgraded Doximity (DOCS) to equal weight from underweight, citing renewed momentum in its business and conservative Q4 guidance. Read more here.

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to Doximity (DOCS – Research Report). The ...

Morgan Stanley analyst Craig Hettenbach upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $53, up from $33.

Record-breaking Q2 earnings, soaring revenue, and bullish analyst upgrades make Doximity the healthcare stock to watch ...

Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high ...

Pavlo Gonchar / SOPA Images / LightRocket / Getty Images Doximity shares surged Friday morning after the company's second quarter results and outlook for the rest of its fiscal year beat estimates.

In the last three months, 9 analysts have published ratings on Doximity DOCS, offering a diverse range of perspectives from ...

The round saw participation from Perplexity CTO Denis Yarats, Kleiner Perkins Scout Fund, Y Combinator, Snorkel AI CEO Alex ...

Doximity, Inc. (NASDAQ:DOCS – Get Free Report) shares reached a new 52-week high on Friday . The company traded as high as $57.10 and last traded at $57.10, with a volume of 272953 shares trading ...